Search

everythinglearnresearchcommunity

for

Search:↓

Genetic variations in FTO and MC4R may contribute to PCOS by affecting obesity.

High testosterone increases heart disease risk in women with PCOS.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Genetic mutations can affect female sexual development, requiring personalized medical care.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Minoxidil and finasteride combined can effectively treat hair loss.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.